Indian companies are accelerating global acquisitions, with over 70 overseas deals worth around $17.3 billion in the first four months of 2026.

Sun Pharma’s recent big-ticket acquisition of US-based Organon has put the spotlight on Indian companies increasingly making global acquisitions to gain market access and enhance capabilities.

There have been more than 70 acquisitions of international companies by Indian-owned businesses in the first four months of 2026, with the total value at about $17.3 billion, according to Bloomberg data sourced by bussinessline. For some deals, the value remains undisclosed, so the total spend could be higher.

Major deals in 2026 (besides Sun Pharma’s) include IKS Health’s $533 million acquisition of TruBridge, Infosys’s $465 million buy of Optimum Healthcare, and Wipro’s $375 million takeover of Mindsprint, among others.

The deal activity was also up in 2024 and 2025, and has been gradually rising after a period of slowdown between 2016 and 2020, when annual outbound acquisitions were in the range of 70-90. As for sectors, tech companies, especially Tier 1 IT service firms, account for the largest share of overseas buys, while industries such as pharmaceuticals, healthcare, and renewable energy are also seeing increasing interest in international assets.

Speaking to businessline, analysts said that in recent years, Indian companies, equipped with better balance sheets, are looking at international assets to expand market access and access capabilities that would take them years of research and development.

“Indian market is one of the most expensive in the world, and with the same scale you get much better deals overseas as the valuations are not that high,” said Sen Abhijit, Partner - Transaction Diligence at Deloitte. Since most acquisitions are of US assets, they also help generate dollar revenues, which act as a good hedge against a depreciating rupee, he said.

Abhijit also noted that, especially in IT, acquisitions help bypass the long gestation of building capabilities such as AI internally when established players are bought.

Sumeet Abrol, Partner and Deals Lifecycle Leader, Grant Thornton Bharat, said that better access to financing is also playing a role. “A lot of the mid-market companies have also been getting creative with financing and other structures such as leverage buyouts, which were earlier bastions of only large corporations,” said Abrol.

Published on April 30, 2026